S.R.O. 361(I)/2007, Islamabad, the 2nd May, 2007

SROS: S.R.O. 361(I)/2007, Islamabad, the 2nd May, 2007 GOVERNMENT OF PAKISTAN MINISTRY OF FINANCE AND REVENUE (REVENUE DIVISION) NOTIFICATION (CUSTOMS) S.R.O. 361(I)/2007, Islamabad, the 2nd May, 2007:- In exercise of the powers conferred by section 19 of the Customs Act, 1969(IV of 1969), the Federal Government is pleased to direct that the following further amendments shall be made in its Notification No.S.R.O.567(I)/2006, dated the 5th June, 2006, namely:- In the aforesaid Notification, in Table-IV,- (a) after serial number 47 in column(1) and the entries relating thereto in columns(2),(3), and(4), the following new serial number and the entries relating thereto shall be inserted, namely:- 47A 2933.9100 Methanone. 5%.; (b) against serial number 55 in column(1), in column(3) in entry(vi), after the words cloxacillin, occurring for the second time, the word sodium shall be inserted; (c) against serial number 58 in column(1), in column(2) for the figure 3002.9090 the figure 3002.2020 shall be substituted; (d) against serial number 59 in column(1), in column(2), for the figure 3002.9090, the figure 3002.2090 shall be substituted; (e) against serial number 62 in column(1), in column(3), after serial number (xliv), the following new serial numbers and the entries relating thereto shall be added, namely:- (xlv) Trastuzumab (xlvi) Rituximab (xlvii) Erlotinib (xlviii) Fludarabine (xlix) Capecitibine (l) Epirubicin (li) Bevacizumab (lii) Ibandronic acid (liii) Disodium Clodronate tetrahydrate (liv) Bicalutamide (lv) Goserelin (lvi) BCG strain…